+87.7%
EEM vs CVS
+62.1%
+25.5%
-17.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -0.7% | +0.2% | -0.5% |
| 7D | +2.0% | -1.9% | +3.9% | +2.0% |
| 30D | +5.1% | -0.3% | +5.4% | +5.1% |
| 3M | +4.6% | -1.1% | +5.7% | +4.6% |
| 6M | +17.8% | +23.7% | -5.9% | +16.9% |
| YTD | +25.8% | +23.0% | +2.8% | +24.7% |
| 1Y | +36.4% | +37.2% | -0.8% | +34.7% |
| All | +87.7% | +62.1% | +25.5% | +83.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling